SMARCA2 and non-small cell lung carcinoma: Furthermore, there is a hypothesis that SMARCA4-deficient NSCLC may acquire a secondary mutation, leading to the loss of BRM protein and resulting in the transformation into the more poorly differentiated SMARCA4-UT.